Insider · CIK 0001690619

Santini Alexander A

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001690619

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.A Award	EVP and CCO	AAward	+19.9K sh	—	—	62,397
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CCO	FTax Payment	−6,813 sh	$1.96	−$13.4K	55,584
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,353 sh	—	—	21,014
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,593 sh	—	—	23,607
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+8,464 sh	—	—	32,071
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+22.9K sh	—	—	54,924
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CCO	FTax Payment	−12.4K sh	$2.77	−$34.4K	42,504
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,353 sh	—	—	0
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,593 sh	—	—	2,592
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−8,464 sh	—	—	8,463
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−22.9K sh	—	—	45,707
2020-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP and CCO	AAward	+70.6K sh	—	—	70,560
2020-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CCO	AAward	+212K sh	—	—	211,690
2019-09-18	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	EVP and CCO	PPurchase	+2,500 sh	$3.23	+$8,075	16,661
2019-09-18	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	EVP and CCO	PPurchase	+2,000 sh	$3.52	+$7,040	18,661
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,352 sh	—	—	7,649
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,593 sh	—	—	10,242
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+8,463 sh	—	—	18,705
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CCO	FTax Payment	−4,544 sh	$5.51	−$25K	14,161
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,352 sh	—	—	2,353
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,593 sh	—	—	5,185
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−8,463 sh	—	—	16,927
2019-02-07	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CCO	AAward	+127K sh	—	—	127,320
2019-02-07	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP and CCO	AAward	+68.6K sh	—	—	68,560
2018-05-23	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	EVP and CCO	PPurchase	+745 sh	$9.78	+$7,286.1	5,297
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,353 sh	—	—	3,612
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,592 sh	—	—	6,204
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CCO	FTax Payment	−1,652 sh	$8.53	−$14.1K	4,552
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,353 sh	—	—	4,705
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,592 sh	—	—	7,778
2018-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP and CCO	AAward	+25.4K sh	—	—	25,390
2018-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CCO	AAward	+71.9K sh	—	—	71,940
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,352 sh	—	—	2,352
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CCO	FTax Payment	−1,093 sh	$16.45	−$18K	1,259
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,352 sh	—	—	7,058
2017-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CCO	AAward	+41.5K sh	—	—	41,470
2017-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP and CCO	AAward	+10.4K sh	—	—	10,370

Recent filings

Accepted (ET)
Apr 244
Santini Alexander A0001127602-20-014492
SEC(opens sec.gov)
Mar 34
Santini Alexander A0001127602-20-008965
SEC(opens sec.gov)
Feb 104
Santini Alexander A0001127602-20-004597
SEC(opens sec.gov)
Sep 194
Santini Alexander A0001127602-19-028812
SEC(opens sec.gov)
Mar 14
Santini Alexander A0001127602-19-009264
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.EVP and CCOLXRX

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 77381